Remove 2019 Remove Insurance Remove Omnicell
article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

In a manual for hemophilia treatment centers, the agency states it is concerned that providers would have no reason to participate in 340B if insurers take the benefit of 340B savings from them. District Court in Washington, D.C., However, the U.S Supreme Court takes up the case in 2022 and ruled in favor of the 340B hospitals.

article thumbnail

Medicare Beneficiaries in Underserved Areas and Pharmacist Provider Status

Omnicell

James Stevenson Chief Clinical Officer, Omnicell Since the beginning of COVID-19, healthcare employment has fallen by 524,000 jobs , resulting in a nationwide shortage of nurses, technicians, and more. A physician shortage is another looming issue. For years, the United States has been predicting a physician shortage.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Legislation that 340B Providers and the Drug Industry Can Both Embrace

Omnicell

More and more commercial insurers are insisting on contract terms that require covered entities to accept reimbursement rates that can be significantly below the rates offered to non-340B providers and pharmacies, resulting in an indirect transfer of 340B savings from the covered entities to the insurance companies and pharmacy benefit managers.

article thumbnail

Three 340B Predictions for the New Year

Omnicell

More states enact laws to prevent discriminatory reimbursement, but federal legislation doesn’t make it to the finish line Since 2019, we’ve seen a growing number of states enact laws to address what 340B providers perceive as discriminatory actions by health care payors.